Quantitative analysis for Novartis AG (NVS) — Health Care: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based forecast, technical and fundamental signals, and insider activity.
Current Q-Score verdict: Buy (69.0) (grade B). 41 signals analyzed (37 differentiated alt-data).
NVS stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-04-29 | $144.04 | $142.25 | $142.94 |
| 2026-05-11 | $147.28 | $144.75 | $145.23 |
| 2026-05-21 | $152.52 | $149.54 | $151.76 |
| 2026-06-03 | $144.26 | $142.26 | $143.66 |
| 2026-06-15 | $153.32 | $151.27 | $151.56 |
| 2026-06-26 | $156.38 | $153.34 | $155.41 |
| 2026-07-09 | $155.47 | $153.79 | $154.62 |
| 2026-07-21 | $159.30 | $153.66 | $153.87 |
| 2026-07-31 | $157.12 | $155.03 | $156.15 |
| 2026-08-12 | $153.43 | $151.82 | $152.32 |
| 2026-08-24 | $158.46 | $156.77 | $158.02 |
| 2026-09-03 | $164.48 | $161.42 | $163.09 |
How Novartis AG stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| AZN | AstraZeneca PLC | $290.7B | — |
| NVO | Novo Nordisk A/S | $200.3B | — |
| SNY | Sanofi | $107.6B | — |
| GSK | GSK plc | $102.1B | — |
View all Health Care stocks by valuation and signals →
Novartis AG (NVS) scores Buy (69.0), and the composite conceals a 64-point disagreement between its dimensions. It is strongest on technicals at 86 and social sentiment at 67, and weakest on analyst consensus at 22. A stock can carry technicals that high while analyst consensus sits at 22; the composite averages that tension away, which is why the breakdown is worth reading before the headline number. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| technicals | 86 |
| social sentiment | 67 |
| analyst consensus | 22 |
StoQuant analyzes 41 signals (37 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.
All StoQuant signals are explained in our knowledge base:
Health Care Hub — Top performers and valuation outliers in Health Care
Get daily updates on Novartis AG (NVS): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
See a sample digest • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and institutional-grade signals. We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/NVS"><img src="https://stoquant.com/badge/NVS.svg" alt="Novartis AG (NVS) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Weekly Q-Score signals and insider buying activity on our highest-conviction stock picks. Email only, no account needed. See a sample digest.